BioElectronics Announces Clinical Trials, New Orthopedics Group

BioElectronics, a developer and marketer of disposable, drug-free medical devices, has announced that its ActiPatch Therapy product is in clinical trials with a major pharmaceutical foot care company.

ActiPatch Therapy is a dermal patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few dollars a day. The patch delivery system and the company's patented technology provide an inexpensive, self-administered equivalent of the operator-administered pulsed electromagnetic energy therapy used extensively worldwide to reduce swelling, relieve pain and to enhance the healing of postsurgical incisions, chronic wounds and orthopedic conditions.

The company also announced the formation of an orthopedics group and that Todd Kislak has joined the company as that group's president.